RxDoctor Payments Data

Maria Bonanni

Gerontology · Philadelphia, PANPI 1821336140

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 93.1% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $23,757, more than ten times the $92 reported in 2021. Among gerontology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,723in general payments, 2019–2025

Across 123 payments — averaging $290.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$33K
  • Azurity Pharmaceuticals, Inc.$2K
  • Bayer$92
  • Travere Therapeutics, Inc.$6

What the payments were for

  • Consulting fees$1,8105%
  • Speaking & faculty fees$20,82558%
  • Travel & lodging$9,62527%
  • Food & beverage$3,45810%
  • Education$60%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,723 in reported general payments places this provider in the 95th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$34,655
Medicare patients
134
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin29$45,043
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid39$8,483
Clonidine47$7,382
Eplerenone59$6,783
Telmisartan77$4,405
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med18$2,152
Amiloride Hcl68$2,002
Spironolactone114$1,842
Droxidopa12$1,708
Olmesartan Medoxomil55$1,440
Amlodipine Besylate143$1,192
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide15$1,178
Metoprolol Succinate40$1,052
Carvedilol51$923
Rosuvastatin Calcium49$919

Paid to pharmacies, not to this prescriber.

Other gerontology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →